Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Redfern AD"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Redfern, AD, Woodhead, FA
Publikováno v:
Thorax; 2017, Vol. 72 Issue: Supplement 3 pA250-A252, 3p
Autor:
Chi LH; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia., Redfern AD; Medical School, University of Western Australia, Perth, WA 6009, Australia., Lim Kam Sian TCC; Cancer Program, Monash Biomedicine Discovery Institute, Clayton, VIC 3168, Australia.; Department of Biochemistry & Molecular Biology, Monash University, Clayton, VIC 3168, Australia., Street IP; Children's Cancer Institute, University of New South Wales, Sydney, NSW 2052, Australia., Burrows AD; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia., Roslan S; Department of Surgery, St. Vincent's Hospital, Fitzroy, VIC 3065, Australia., Daly RJ; Cancer Program, Monash Biomedicine Discovery Institute, Clayton, VIC 3168, Australia.; Department of Biochemistry & Molecular Biology, Monash University, Clayton, VIC 3168, Australia., Anderson RL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3052, Australia.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Aug 23; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 23.
Autor:
Hayne D; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; South Metropolitan Health Service, Murdoch, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Ong K; South Metropolitan Health Service, Murdoch, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Swarbrick N; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia.; Department of Anatomical Pathology, PathWest Laboratory Medicine, Perth, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., McCombie SP; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; South Metropolitan Health Service, Murdoch, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Moe A; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Hawks C; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; South Metropolitan Health Service, Murdoch, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Viswambaram P; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Conduit C; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia.; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Personalised Oncology, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Liow E; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia.; Monash Health, Clayton, Victoria, Australia., Spalding L; Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia.; University of Western Australia Centre for Medical Research, Nedlands, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Lim J; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Ferguson T; South Metropolitan Health Service, Murdoch, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Meehan K; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia., Davis ID; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia.; Monash University, Melbourne, Victoria, Australia.; Eastern Health, Melbourne, Victoria, Australia., Redfern AD; UWA Medical School, University of Western Australia, Crawley, Western Australia, Australia.; South Metropolitan Health Service, Murdoch, Western Australia, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia.
Publikováno v:
BJU international [BJU Int] 2024 Aug; Vol. 134 (2), pp. 283-290. Date of Electronic Publication: 2024 Mar 12.
Autor:
Kim JS; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia., Taaffe DR; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia., Galvão DA; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia., Clay TD; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.; Department of Medical Oncology, St John of God Subiaco Hospital, Perth, WA, Australia., Redfern AD; Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, WA, Australia.; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia., Gray ES; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.; Centre for Precision Health, Edith Cowan University, Joondalup, WA, Australia., Newton RU; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia. r.newton@ecu.edu.au.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia. r.newton@ecu.edu.au.; School of Human Movement and Nutrition Sciences, University of Queensland, St Lucia, QLD, Australia. r.newton@ecu.edu.au.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Jul 01; Vol. 24 (1), pp. 784. Date of Electronic Publication: 2024 Jul 01.
Autor:
Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia; Garvan Institute of Medical Research, Sydney, NSW, Australia. Electronic address: louise.emmett@svha.org.au., Subramaniam S; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Bankstown-Lidcombe Hospital, Sydney, NSW, Australia., Crumbaker M; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, NSW, Australia; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia; Garvan Institute of Medical Research, Sydney, NSW, Australia; Macquarie University Hospital, Sydney, NSW, Australia., Nguyen A; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia., Joshua AM; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia; Garvan Institute of Medical Research, Sydney, NSW, Australia., Weickhardt A; Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Lee ST; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; Department of Medicine and Department of Surgery, University of Melbourne, Melbourne, VIC, Australia., Ng S; Department of Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia; Department of Oncology, University of Western Australia, Perth, WA, Australia., Francis RJ; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia., Goh JC; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Queensland University of Technology, Brisbane, QLD, Australia., Pattison DA; Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; School of Medicine, University of Queensland, Brisbane, QLD, Australia., Tan TH; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia., Kirkwood ID; Nuclear Medicine, PET and Bone Densitometry, Royal Adelaide Hospital, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia., Gedye C; Department of Medical Oncology, Calvary Mater Newcastle, Waratah, NSW, Australia., Rutherford NK; Department of Nuclear Medicine, Hunter New England Health, Newcastle, NSW, Australia., Sandhu S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Kumar AR; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Pook D; Department of Oncology, Monash Health, Melbourne, VIC, Australia., Ramdave S; Monash Health Imaging, Monash Health, Melbourne, VIC, Australia., Nadebaum DP; Department of Oncology, Alfred Health, Melbourne, VIC, Australia., Voskoboynik M; Department of Oncology, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Monash University, Melbourne, VIC, Australia., Redfern AD; Medical School, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Perth, WA, Australia., Macdonald W; Medical School, University of Western Australia, Perth, WA, Australia; Department of Nuclear Medicine, Fiona Stanley Hospital, Perth, WA, Australia., Krieger L; Genesis Care North Shore, Sydney, NSW, Australia., Schembri G; Nuclear Medicine, Royal North Shore Hospital, Sydney, NSW, Australia., Chua W; Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia; Western Sydney University, Sydney, NSW, Australia., Lin P; South Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, NSW, Australia., Horvath L; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia., Bastick P; Department of Medical Oncology, St George Hospital, Sydney, NSW, Australia., Butler P; Department of Nuclear Medicine, St George Hospital, Sydney, NSW, Australia., Zhang AY; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Macquarie University Hospital, Sydney, NSW, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia., Yip S; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Thomas H; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Langford A; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Hofman MS; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., McJannett M; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, NSW, Australia., Martin AJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia., Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia., Davis ID; Monash University Eastern Health Clinical School, Melbourne, VIC, Australia; Eastern Health, Melbourne, VIC, Australia.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 May; Vol. 25 (5), pp. 563-571. Date of Electronic Publication: 2024 Apr 12.
Autor:
Chi LH; Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Redfern AD; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA, Australia., Roslan S; Department of Surgery, St. Vincent's Hospital, Fitzroy, VIC, Australia., Street IP; Children's Cancer Institute, University of New South Wales, New South Wales, Australia., Burrows AD; Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Anderson RL; Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, VIC, 3084, Australia. robin.anderson@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia. robin.anderson@onjcri.org.au.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia. robin.anderson@onjcri.org.au.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. robin.anderson@onjcri.org.au.
Publikováno v:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Apr 30; Vol. 22 (1), pp. 248. Date of Electronic Publication: 2024 Apr 30.
Autor:
Crespo-Garcia C; Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Campbell JP; Department for Health, University of Bath, Bath, United Kingdom., Taaffe DR; Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Peddle-McIntyre CJ; Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Jeffery E; Curtin School of Population Health, Curtin University, Perth, Western Australia, Australia., Galvao DA; Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Redfern AD; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia., Newton RU; Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.; School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Queensland, Australia.
Publikováno v:
Exercise immunology review [Exerc Immunol Rev] 2024; Vol. 30, pp. 26-48.
Autor:
Hofman MS; Prostate Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: michael.hofman@petermac.org., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, NSW, Australia; Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia., Sandhu S; Prostate Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia., Iravani A; Prostate Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Buteau JP; Prostate Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia., Joshua AM; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia., Goh JC; Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Queensland University of Technology, Brisbane, QLD, Australia., Pattison DA; Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; School of Medicine, University of Queensland, Brisbane, QLD, Australia., Tan TH; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Kirkwood ID; Department of Nuclear Medicine and PET, Royal Adelaide Hospital, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia., Ng S; Department of Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia., Francis RJ; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia., Gedye C; Department of Medical Oncology, Calvary Mater Newcastle, Waratah, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Rutherford NK; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Department of Nuclear Medicine, Hunter New England Health, New Lambton, NSW, Australia., Weickhardt A; Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Scott AM; Department of Medicine, Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia., Lee ST; Department of Medicine, Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia., Kwan EM; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia., Azad AA; Prostate Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia., Ramdave S; Monash Health Imaging, Monash Health, Melbourne, VIC, Australia., Redfern AD; Medical School, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Perth, WA, Australia., Macdonald W; Medical School, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Perth, WA, Australia; Department of Nuclear Medicine, Fiona Stanley Hospital, Perth, WA, Australia., Guminski A; Department of Medical Oncology, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia., Hsiao E; Department of Nuclear Medicine and PET, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia., Chua W; Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia., Lin P; Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, NSW, Australia., Zhang AY; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Macquarie University Hospital, Sydney, NSW, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia., Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia., Williams SG; Prostate Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia., Martin AJ; Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Davis ID; Monash University Eastern Health Clinical School, Melbourne, VIC, Australia; Eastern Health Department of Cancer Services, Eastern Health, Melbourne, VIC, Australia.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Jan; Vol. 25 (1), pp. 99-107. Date of Electronic Publication: 2023 Nov 30.
Autor:
Kim JS; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia., Taaffe DR; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia., Galvão DA; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia., Clay TD; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.; Department of Oncology, St John of God Subiaco Hospital, Perth, WA, Australia., Redfern AD; Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, WA, Australia.; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia., Hart NH; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.; School of Sport, Exercise, and Rehabilitation, University of Technology Sydney, Moore Park, NSW, Australia., Gray ES; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.; Centre of Precision Health, Edith Cowan University, Joondalup, WA, Australia., Ryan CJ; Medical School, University of Minnesota, Minneapolis, MN, USA., Kenfield SA; Departments of Urology and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA., Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Newton RU; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia. r.newton@ecu.edu.au.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia. r.newton@ecu.edu.au.; School of Human Movement and Nutrition Sciences, University of Queensland, St Lucia, QLD, Australia. r.newton@ecu.edu.au.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Dec; Vol. 26 (4), pp. 795-801. Date of Electronic Publication: 2022 Nov 29.